LIFS — LifeSafe Holdings Income Statement
0.000.00%
Last trade - 00:00
- £4.60m
- £5.04m
- £4.03m
2019 September 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 15 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0.036 | 0.095 | 0.67 | 4.03 |
Cost of Revenue | ||||
Gross Profit | -0.008 | 0.007 | 0.312 | 2.3 |
Selling / General / Administrative Expenses | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 0.654 | 0.789 | 2.17 | 6.82 |
Operating Profit | -0.618 | -0.694 | -1.5 | -2.79 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.718 | -0.693 | -1.54 | -2.99 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.64 | -0.667 | -1.52 | -2.81 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.64 | -0.667 | -1.52 | -2.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.64 | -0.667 | -1.52 | -2.81 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.033 | -0.032 | -0.068 | -0.104 |
Dividends per Share |